Mihajlo Gjeorgjievski, MD
Gastroenterology · Atlanta, GANPI 1770998577
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $31,514 with a category attached, or 79.3%. Boston Scientific accounts for 80.5% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $26,165 and has fallen 89.1% since, to $2,860 in 2025. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $286.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$25K
- Conmed Corporation$3K
- AbbVie$915
- Ovesco Endoscopy USA, Inc.$692
- Intra-sana Laboratories$500
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$194
- plus $892 from 19 others
What the payments were for
- Consulting fees$2,1407%
- Speaking & faculty fees$5002%
- Grants$25,00079%
- Travel & lodging$1,2274%
- Food & beverage$2,6258%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $25,384 |
| Conmed Corporation | 5 | $2,937 |
| AbbVie | 42 | $915 |
| Ovesco Endoscopy USA, Inc. | 1 | $692 |
| Intra-sana Laboratories | 1 | $500 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $194 |
| Intercept Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $108 |
| Cook Medical LLC | 2 | $106 |
| Vivus LLC | 5 | $101 |
| Medtronic | 4 | $65 |
| Merck | 3 | $54 |
| Johnson & Johnson | 3 | $52 |
| Apollo Endosurgery US Inc | 1 | $44 |
| Bristol Myers Squibb | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Organon | 1 | $23 |
| Ambu Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Endogastric Solutions, Inc | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - BILIARY DEVICES$25,000
- Reltone 200 Mg$500
- Reltone 400 Mg$500
- CONMED BILIARY$251
- SpyScope DS$142
- OCALIVA$125
- CONMED HEMOSTASIS$121
- CONMED DILATION$121
- Mavyret$100
- Creon$100
How this compares
$31,514 in reported general payments places this provider in the 90th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $468 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Atlanta
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Marc SonenshineAtlanta$201K
- Julia LiuAtlanta$163K
- Huiming HonAtlanta$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.